发明名称 |
Piperazine derivatives for blocking Cav2.2 calcium channels |
摘要 |
The present invention relates to novel piperazine compounds; to pharmaceutical compositions containing the compounds; and to the use of the compounds in therapy to treat diseases for which blocking the Cav2.2 calcium channels is beneficial and to treat diseases for which blocking the Cav2.2 and Cav3.2 calcium channels is beneficial, e.g. to treat pain. |
申请公布号 |
US8697703(B2) |
申请公布日期 |
2014.04.15 |
申请号 |
US201113521680 |
申请日期 |
2011.01.14 |
申请人 |
HEER JAG PAUL;CRIDLAND ANDREW PETER;NORTON DAVID;CONVERGENCE PHARMACEUTICALS LIMITED |
发明人 |
HEER JAG PAUL;CRIDLAND ANDREW PETER;NORTON DAVID |
分类号 |
A61K31/495 |
主分类号 |
A61K31/495 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|